// App-Quantinova.ai

TP22 2014 ASA : Intra-procedural Heparin Increases Mortality and Reduces Rates of Favorable Outcome in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment.

Researchers

Presenter

  • Aveen Saed

Principal Investigators

  • Tanya Mohindroo

  • Mushtaq Qureshi

  • Sayed Hussain

Medical Centers

  • Zeenat Qureshi Stroke Inst and CentraCare Health, St. Cloud, MN

  • Zeenat Qureshi Stroke Inst and CentraCare Health, St. Cloud, MN

  • Michigan State University, Lansing, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Intracerebral hemorrhage

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved